Elevated GM-CSF levels in the glioma microenvironment can promote MDSCs’ activation, thereby up-regulating the expression of the inhibitory cytokine TGF-β and promoting the formation of an immunosuppressive microenvironment [20]. This evidence concerns the gene CSF2 and central nervous system cancer.